Superinfection following smallpox vaccination (vaccinia), United States: Surveillance January 2003 through January 2004

Clinical Infectious Diseases

Volumn 39, Issue 11, 2004, Pages 1660-1666

  Vellozzi, Claudia ^a,b,d   Averhoff, Francisco ^a   Lane, J Michael ^b   Wen, Xiaojun ^a,c   Moore, Anne C ^a   Santibanez, Scott ^a   Kroger, Andrew ^a   Hasbrouck, La Mar ^a   Kennedy, Allison ^a   Casey, Christine G ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c LOCKHEED MARTIN   (United States)

^d Logistics Health Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; SMALLPOX VACCINE;

ADULT; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BIOLOGICAL WARFARE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; EDEMA; ERYTHEMA; FEMALE; FOLLICULITIS; HUMAN; LYMPHADENOPATHY; MALAISE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SKIN INDURATION; SMALLPOX; SUPERINFECTION; THORAX PAIN; UNITED STATES; VACCINIA;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SUPERINFECTION; UNITED STATES; VACCINIA;

EID: 9644260653     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/425617     Document Type: Review

References (21)

1. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morb Mortal Wkly Rep 2001; 50:1-25.
2. Notices. Fed Regist 28 January 2003; 68:4212-3. Available at http://www.gpoaccess.gov. Accessed 29 October 2004.
3. Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA 2003; 289:3278-82.
4. Neff JM, Lane JM, Pert JH, et al. Complications of smallpox vaccination. National Survey in the United States, 1963. N Engl J Med 1967; 276:126-32.
5. Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep 2003; 52:1-28.
6. Chen RT, Rastogi SC, Mullen JR. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994; 12:542-50.
7. Kipreos V. Transcript. Data and information management of the smallpox vaccine program, 2002. Available at: http://www.bt.cdc.gov/agent/smallpox/ training/webcast/dec2002. Accessed 5 May 2004.
8. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: national surveillance in the United States. N Engl J Med 1969; 281:1201-8.
9. Chen RT, Davis RL, Sheedy KM. Safety of immunizations. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: W. B. Saunders, 2004:1557-81.
10. Modlin JF. A mass smallpox vaccination campaign: reasonable or irresponsible? Eff Clin Pract 2002; 5:98-9.
11. Fauci AS. Smallpox vaccination policy-the need for dialogue. N Engl J Med 2002; 346:1319-20.
12. Sauri MA. Responses to smallpox vaccine. N Engl J Med 2002; 347: 689-90.
13. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970; 122:303-9.
14. Burwick FC. Common respiratory symptoms. In: Rakel RE, ed. Saunders manual of medical practice. 2nd ed. Philadelphia: W. B. Saunders, 2000:150-2.
15. Gwaltney JM, Bisno AL. Pharyngitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:656-62.
16. Swartz MN. Cellulitis and subcutaneous tissue infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:1037-57.
17. Fulginiti VA, Papier A, Lane MJ, Neff JM, Herderson DA. Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions. Clin Infect Dis 2003; 37:241-50.
18. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 2002; 346:1265-74.
19. Casey CG, Pool V, Mootrey G, et al. Robust takes (RT) masquerading as "cellulitis" in smallpox vaccinees [abstract 818]. In: Program and abstracts of the 41st Annual Meeting of Infectious Diseases Society of America (San Diego). Alexandria: Infectious Diseases Society of America, 2003.
20. Neff JM, Levine RH, Lane JM, et al. Complications of smallpox vaccination: United States 1963. II. Results obtained by four statewide surveys. Pediatrics 1967; 39:916-23.
21. Centers for Disease Control and Prevention. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52:1-16.